datetime,headline,summary,related,lang,source
2020-10-27 06:23:51-05:00,"Ophthalmic Devices Market Top Key Players- Hoya Group, Gulden Ophthalmics, FCI Ophthalmics, Glaukos Corporation, STAAR Surgical Growth Trends, quantitative analysis Industry Analysis and Market Dynamics of the Global Market, 2020 to 2027","Summary of the Ophthalmic Devices Market Report Due to the various economic, technological, research & development and geographical aspects, the Ophthalmic Devices Market would gain a healthy CAGR and market size from 2020 to 2027. The growth trend would",GKOS,en,OpenPR
2020-10-20 20:46:49-05:00,Glaukos Corp (NYSE:GKOS) Expected to Post Quarterly Sales of $54.19 Million,"Equities analysts expect that Glaukos Corp (NYSE:GKOS) will report $54.19 million in sales for the current quarter, Zacks reports. Five analysts have provided estimates for Glaukos’ earnings, with estimates ranging from $52.50 million to $55.20 million. Glaukos reported sales of $58.51 million in the same quarter last year, which would suggest a negative year-over-year growth […]",GKOS,en,US Banking News
2020-10-19 12:16:42-05:00,Brokerages Expect Glaukos Corp (NYSE:GKOS) Will Post Earnings of -$0.46 Per Share,"Wall Street analysts expect Glaukos Corp (NYSE:GKOS) to announce ($0.46) earnings per share for the current fiscal quarter, according to Zacks. Five analysts have issued estimates for Glaukos’ earnings, with the highest EPS estimate coming in at ($0.28) and the lowest estimate coming in at ($0.54). Glaukos reported earnings per share of ($0.10) during the […]",GKOS,en,Transcript Daily
2020-10-01 01:32:15-05:00,"Glaucoma Surgery Devices Market With Top Players likeAbbott Laboratories, Alcon, ASICO, LLC. Carl Zeiss Meditec AG, Glaukos Corporation, Iridex Corporation, Katalyst Surgical Lumenis Ltd. Nidek Co., Ltd., Ziemer Ophthalmic Systems AG",Glaucoma is a small device that is surgically inserted into the eye to increase the outflow of intraocular fluid and lessen high eye pressure. Surgery includes either laser treatment or making a cut in the eye to reduce intraocular stress.,GKOS,en,OpenPR
2020-08-06 15:54:07-05:00,Glaukos : GAAP to Non-GAAP Reconciliation Tables – Q2 2020 | MarketScreener,"GLAUKOS CORPORATION GAAP to Non-GAAP Reconciliations … | August 6, 2020",GKOS,en,MarketScreener
2020-06-06 10:31:38-05:00,Glaukos (GKOS) Up 13.8% Since Last Earnings Report: Can It Continue?,Glaukos (GKOS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,GKOS,en,Zacks Investment Research
2020-05-08 02:50:00-05:00,Glaukos (GKOS) Q1 Earnings and Revenues Miss Estimates,Glaukos (GKOS) witnessed a contraction in gross margin but year-over-year revenue surge in Q1.,GKOS,en,Zacks Investment Research
2020-05-07 19:40:11-05:00,"Glaukos (GKOS) Reports Q1 Loss, Misses Revenue Estimates","Glaukos (GKOS) delivered earnings and revenue surprises of -25.71% and -0.10%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?",GKOS,en,Zacks Investment Research
2020-05-07 15:24:07-05:00,Glaukos Corporation : Announces First Quarter 2020 Financial Results | MarketScreener,"Glaukos Corporation , an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced… | May 7, 2020",GKOS,en,MarketScreener
2020-03-19 06:37:15-05:00,"The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) Biomerica, Inc. (NASDAQ: BMRA )( announced commencement of international shipment of rapid COVID-19 test) BioNTech SE – ADR (NASDAQ: BNTX ) Imara Inc (NASDAQ: IMRA ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on March 18) 89bio Inc (NASDAQ: ETNB ) AC Immune SA (NASDAQ: ACIU ) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adamis Pharmaceuticals Corp (NASDAQ: ADM ) Adial Pharmaceuticals Inc (NASDAQ: ADIL ) ADMA Biologics Inc (NASDAQ: ADMA ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Agenus Inc (NASDAQ: AGEN ) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) Aikido Pharma Inc (NASDAQ: AIKI ) Akorn, Inc. (NASDAQ: AKRX ) Alkermes Plc (NASDAQ: ALKS ) Allogene Therapeutics Inc (NASDAQ: ALLO ) Alterity Therapeutics Ltd (NASDAQ: ATHE ) AMAG Pharmaceuticals, Inc.","GKOS,GLYC,GLMD",en,Benzinga
2020-03-10 08:19:55-05:00,"The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index","Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Enzo Biochem, Inc. (NYSE: ENZ ) Centogene NV (NASDAQ: CNTG ) Inovio Pharmaceuticals Inc (NASDAQ: INO ) Spherix Inc (NASDAQ: SPEX ) ( added to Friday's advance on clinching an option agreement for coronavirus treatment) Down In The Dumps (Biotech stocks that hit 52-week lows March 9.) ABIOMED, Inc. (NASDAQ: ABMD ) Acasti Pharma Inc (NASDAQ: ACST ) Achieve Life Sciences Inc (NASDAQ: ACHV ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) ADMA Biologics Inc (NASDAQ: ADMA ) Aeglea Bio Therapeutics Inc (NASDAQ: AGLE ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Affimed NV (NASDAQ: AFMD ) Akers Biosciences Inc (NASDAQ: AKER ) Akorn, Inc. (NASDAQ: AKRX ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Alexion Pharmaceuticals, Inc.",GKOS,en,Benzinga
2020-03-06 08:49:43-05:00,"The Daily Biotech Pulse: Breakthrough Device Designation For Neuronetics, AbbVie Receives European Label Expansion, AstraZeneca Flunks Late-Stage Study","Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit hit 52-week highs March 5.) Arcus Biosciences Inc (NYSE: RCUS ) Arcturus Therapeutics Ltd (NASDAQ: ARCT ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Centogene NV (NASDAQ: CNTG ) Cue Biopharma Inc (NASDAQ: CUE ) Forty Seven Inc (NASDAQ: FTSV ) Inovio Pharmaceuticals Inc (NASDAQ: INO ) Molecular Templates Inc (NASDAQ: MTEM ) Natera Inc (NASDAQ: NTRA ) Ocular Therapeutix Inc (NASDAQ: OCUL ) (Piper Sandler lifted the price target for the shares from $7 to $11) Quest Diagnostics Inc (NYSE: DGX ) (announced plans to launch a COVID-19 test service) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Syndax Pharmaceuticals Inc (NASDAQ: SNDX ) Zynex Inc. (NASDAQ: ZYXI ) Down In The Dumps (Biotech stocks that hit 52-week lows March 5.) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) AngioDynamics, Inc. (NASDAQ: ANGO ) ANI Pharmaceuticals Inc Common Stock (NASDAQ: ANIP ) Aytu Bioscience Inc (NASDAQ: AYTU ) Celcuity Inc (NASDAQ: CELC ) Chembio Diagnostics Inc (NASDAQ: CEMI ) Eagle Pharmaceuticals Inc (NASDAQ: EGRX ) Eiger Biopharmaceuticals Inc (NASDAQ: EIGR ) Enlivex Therapeutics Ltd (NASDAQ: ENLV ) Evogene Ltd (NASDAQ: EVGN ) EXACT Sciences Corporation (NASDAQ: EXAS ) Glaukos Corp (NYSE: GKOS ) Lantheus Holdings Inc (NASDAQ: LNTH ) Mylan NV (NASDAQ: MYL ) Neurometrix Inc (NASDAQ: NURO ) Organogenesis Holdings Inc (NASDAQ: ORGO ) Orthofix Medical Inc (NASDAQ: OFIX ) Passage Bio Inc (NASDAQ: PASG ) (went public last week) Polarityte Inc (NASDAQ: PTE ) STRATA Skin Sciences Inc (NASDAQ: SSKN ) SurModics, Inc. (NASDAQ: SRDX ) (reacted to first-quarter results) T2 Biosystems Inc (NASDAQ: TTOO ) Xeris …",GKOS,en,Benzinga
2020-03-02 08:37:00-05:00,Glaukos (GKOS) Q4 Earnings and Revenues Surpass Estimates,"Glaukos (GKOS) fourth-quarter results benefit from revenue growth. However, rise in operating expenses remains a concern.",GKOS,en,Zacks Investment Research
2019-12-06 11:31:10-05:00,Why Is Glaukos (GKOS) Up 1.2% Since Last Earnings Report?,Glaukos (GKOS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,GKOS,en,Zacks Investment Research
2019-11-16 20:40:23-05:00,Zacks: Brokerages Expect Glaukos Corp (NYSE:GKOS) Will Announce Quarterly Sales of $59.96 Million,"Brokerages predict that Glaukos Corp (NYSE:GKOS) will announce sales of $59.96 million for the current quarter, Zacks reports. Three analysts have provided estimates for Glaukos’ earnings, with the lowest sales estimate coming in at $59.48 million and the highest estimate coming in at $60.50 million. Glaukos reported sales of $54.08 million during the same quarter […]",GKOS,en,Modern Readers
2019-11-08 03:08:00-05:00,"Glaukos (GKOS) Q3 Loss Narrower Than Expected, '19 View Up","Glaukos' (GKOS) Q3 revenues surge year over year. Also, the company raises 2019 revenue guidance.",GKOS,en,Zacks Investment Research
2019-11-06 16:29:30-05:00,"Glaukos EPS beats by $0.05, beats on revenue",Glaukos (GKOS): Q3 Non-GAAP EPS of -$0.10 beats by $0.05; GAAP EPS of -$0.37 misses by $0.21. Revenue of $58.5M (+33.3% Y/Y) beats by $1.54M. Press Release,GKOS,en,Seeking Alpha
2019-10-30 09:34:01-05:00,Glaukos (GKOS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release,Glaukos (GKOS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,GKOS,en,Zacks Investment Research
2019-09-06 08:31:45-05:00,Why Is Glaukos (GKOS) Up 2.3% Since Last Earnings Report?,Glaukos (GKOS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,GKOS,en,Zacks Investment Research
2019-08-12 01:40:00-05:00,"Glaukos (GKOS) Q2 Loss Wider Than Estimates, '19 View Raised",Glaukos (GKOS) raises 2019 revenues view; optimistic about Avedro buyout.,GKOS,en,Zacks Investment Research
2019-08-08 06:11:00-05:00,"The Daily Biotech Pulse: Glaukos To Buy Avedro, Mixed Adcom Vote For Gilead, Dynavax Offering","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 7) Akero Therapeutics Inc (NASDAQ: AKRO ) Allakos Inc (NASDAQ: ALLK ) Cytokinetics, Inc. (NASDAQ: CYTK ) Guardant Health Inc (NASDAQ: GH ) (reacted to strong second-quarter results) Morphic Holding Inc (NASDAQ: MORF ) West Pharmaceutical Services Inc. (NYSE: WST ) Down In The Dumps (Biotech stocks hitting 52-week lows on Aug. 7) ABIOMED, Inc. (NASDAQ: ABMD ) Assertio Therapeutics Inc (NASDAQ: ASRT ) Bellicum Pharmaceuticals Inc (NASDAQ: BLCM ) Bicycle Therapeutics PLC (NASDAQ: BCYC ) BioCardia Inc (NASDAQ: BCDA ) BIOLINERX LTD/S ADR (NASDAQ: BLRX ) Biopharmx Corp NYSE: (BPMX) CAN-FITE BIOPHA/S ADR (NYSE: CANF ) CELLECT BIOTECH/S ADR (NASDAQ: APOP ) Cellular Biomedicine Group Inc (NASDAQ: CBMG )(reacted to second-quarter results) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX )(reported second-quarter results) Guardion Health Sciences Inc (NASDAQ: GHSI )(announced common stock offering of 9.","GILD,GKOS,GH",en,Benzinga
2019-06-07 08:30:46-05:00,Glaukos (GKOS) Down 2.5% Since Last Earnings Report: Can It Rebound?,Glaukos (GKOS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,GKOS,en,Zacks Investment Research
2019-05-10 00:24:18-05:00,Glaukos (GKOS) Q1 2019 Earnings Call Transcript,"GKOS earnings call for the period ending March 31, 2019.",GKOS,en,The Motley Fool
2019-05-08 21:23:19-05:00,Glaukos Corporation (GKOS) CEO Tom Burns on Q1 2019 Results - Earnings Call Transcript,No summary available.,GKOS,en,Seeking Alpha
2019-05-08 18:35:05-05:00,"Glaukos (GKOS) Reports Q1 Loss, Tops Revenue Estimates","Glaukos (GKOS) delivered earnings and revenue surprises of 66.67% and 7.77%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?",GKOS,en,Zacks Investment Research
2019-05-08 15:20:58-05:00,"Glaukos beats by $0.07, beats on revenue",No summary available.,GKOS,en,Seeking Alpha
2019-05-01 09:32:43-05:00,Analysts Estimate Glaukos (GKOS) to Report a Decline in Earnings: What to Look Out for,Glaukos (GKOS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,GKOS,en,Zacks Investment Research
2019-03-22 07:16:07-05:00,"The Daily Biotech Pulse: Immutep Gets US Patent, Conatus NASH Disappointment, Eisai Moves On After Aducanumab Setback","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on March 21) Abbott Laboratories (NYSE: ABT ) Baxter International Inc (NYSE: BAX ) Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN ) CareDx Inc (NASDAQ: CDNA ) Catalyst Pharmaceuticals Inc (NASDAQ: CPRX ) CYCLERION THERA/SH (NASDAQ: CYCNV ) Glaukos Corp (NYSE: GKOS ) Masimo Corporation (NASDAQ: MASI ) Merck & Co., Inc. (NYSE: MRK ) Qiagen NV (NYSE: QGEN ) Uniqure NV (NASDAQ: QURE ) Veracyte Inc (NASDAQ: VCYT ) XBiotech Inc (NASDAQ: XBIT ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech stocks hitting 52-week lows on March 21) Biogen Inc (NASDAQ: BIIB )( discontinued development of one of its Alzheimer's candidate aducanumab) Unity Biotechnology Inc (NASDAQ: UBX ) Stock In Focus Immutep Granted U.S. Patent For its Cancer Treatment Method Australian biotech IMMUTEP LTD/S ADR (NASDAQ: IMMP ) has been granted a new patent entitled … Full story available on Benzinga.",GKOS,en,Benzinga
2019-03-21 06:51:16-05:00,"The Daily Biotech Pulse: Biogen Plummets, FDA Greenlights Sleep Disorder Drug, Cellular Biomedicine Offering","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on March 20) AstraZeneca plc (NYSE: AZN ) BioDelivery Sciences International, Inc. (NASDAQ: BDSI ) Cytokinetics, Inc. (NASDAQ: CYTK )(Following planned interim analysis, the company along with partner Amgen, Inc. (NASDAQ: AMGN ) (announced a large-scale Phase 3 study evaluating their cardiac myosin activator omecamtiv mecarbil in 8000 heart failure patients will continue unchanged.) Dr.Reddy's Laboratories Ltd (NYSE: RDY ) Glaukos Corp (NYSE: GKOS ) Millendo Therapeutics Inc (NASDAQ: MLND ) Orthopediatrics Corp (NASDAQ: KIDS ) Qiagen NV (NYSE: QGEN ) Veracyte Inc (NASDAQ: VCYT ) XBiotech Inc (NASDAQ: XBIT ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on March 20) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Dynavax Technologies Corporation (NASDAQ: DVAX ) Evogene Ltd (NASDAQ: EVGN ) G1 Therapeutics Inc (NASDAQ: GTHX ) resTORbio, Inc. (NASDAQ: TORC ) (priced its common stock offering …",GKOS,en,Benzinga
2019-03-20 06:46:35-05:00,"The Daily Biotech Pulse: FDA Nod For Sage's Postpartum Depression Drug, Pfizer Invests In Gene Therapy Company","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on March 19) Abbott Laboratories (NYSE: ABT ) AstraZeneca plc (NYSE: AZN ) Axsome Therapeutics Inc (NASDAQ: AXSM ) CYCLERION THERA/SH (NASDAQ: CYCNV ) Glaukos Corp (NYSE: GKOS ) Millendo Therapeutics Inc (NASDAQ: MLND )(initiates Phase 2b/3 study for its investigational candidate livoletide for treating Prader-Willi syndrome) Orthopediatrics Corp (NASDAQ: KIDS ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech stocks hitting 52-week lows on March 19) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) resTORbio, Inc. (NASDAQ: TORC ) (announced a common stock offering) See Also: Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates Stock In Focus Sage Gets FDA Approval For Postpartum Depression Drug SAGE Therapeutics Inc (NASDAQ: SAGE ) said the FDA has approved its Zulresso, chemically brexanolone, injection for the treatment of postpartum depression.",GKOS,en,Benzinga
